How Continuous Glucose Monitors Are Spreading Beyond Diabetes

Lucas and Luna explore how continuous glucose monitors are moving from a niche diabetes tool to a mainstream wellness device for athletes, biohackers, and the general public. They examine the science behind CGMs, the key players like Abbott and Dexcom, the controversy over using them without medical need, and what the data really shows about glucose variability in non-diabetics. Specific focus on the 2024-2025 boom in prescription-free CGM access through companies like Levels and Nutrisense, and the emerging evidence on personalized nutrition responses. The episode also touches on the FDA's evolving stance and the economics of a potential mass market for wearable biosensors. #ContinuousGlucoseMonitor #CGM #WearableTech #DigitalHealth #Diabetes #Biohacking #Abbott #Dexcom #Levels #Nutrisense #GlucoseMonitoring #HealthTech #Wearables #PersonalizedNutrition #FDA #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo